NEORX CORPORATION CHANGE OF CONTROL AGREEMENTChange of Control Agreement • June 29th, 2005 • Neorx Corp • In vitro & in vivo diagnostic substances
Contract Type FiledJune 29th, 2005 Company IndustryThis Change of Control Agreement (this “Agreement”), effective as of JUNE 23, 2005, is entered into by and between NEORX CORPORATION, a Washington corporation (as supplemented by Section 13, the “Company”), and David A. Karlin (the “Executive”).
NEORX CORPORATION KEY EXECUTIVE SEVERANCE AGREEMENTKey Executive Severance Agreement • June 29th, 2005 • Neorx Corp • In vitro & in vivo diagnostic substances
Contract Type FiledJune 29th, 2005 Company IndustryThis Key Executive Severance Agreement (VP) (this “Agreement”), effective as of JUNE 23, 2005, is entered into by and between NEORX CORPORATION, a Washington corporation (as supplemented by Section 10, the “Company”), and David A. Karlin (the “Executive”).